Written by Klarity Editorial Team
Published: Jul 17, 2026

Last updated: July 17, 2026
Quick facts: UnitedHealthcare commercial plans in New Hampshire use OptumRx as their pharmacy benefit manager (PBM). Most generic antidepressants are covered at Tier 1. 2 with no prior authorization required. Brand-name medications and specialty treatments like Spravato (esketamine) typically require prior authorization and step therapy. New Hampshire’s EPCS law (RSA 318-B:21-a) is notably broad. It covers all controlled substance schedules II through IV, meaning Spravato (Schedule III) requires an electronic prescription in NH, unlike in many other states. Coverage details vary by specific plan, employer, and formulary. Always verify your benefits before booking an appointment.
If you’re a New Hampshire resident with UnitedHealthcare (UHC) insurance and you’ve been struggling with depression, understanding your coverage can feel like navigating a maze. This guide breaks down what UHC plans in New Hampshire typically cover for depression treatment in 2026. Including medications, therapy, and telehealth. So you can make informed decisions about your care.
See If Your UHC Plan May Cover Depression Treatment →
UnitedHealthcare is one of the largest health insurers operating in New Hampshire, offering plans across the individual marketplace, employer-sponsored group market, and Medicare Advantage (through AARP UnitedHealthcare). The plan’s pharmacy benefits are administered by OptumRx, UHC’s in-house PBM.
Under the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and New Hampshire’s own parity statute. RSA 417-E:1 et seq.. UHC plans are required to cover mental health services, including depression treatment, on terms no more restrictive than coverage for comparable medical conditions. This means deductibles, copays, prior authorization requirements, and visit limits must be applied equally to mental health and medical benefits.
New Hampshire enforces parity through the NH Insurance Department (1-800-852-3416). If you believe your plan is applying more restrictive rules to your depression care than to comparable medical conditions, you have the right to file a complaint.
New Hampshire has one of the broadest Electronic Prescribing for Controlled Substances (EPCS) laws in the United States. Under RSA 318-B:21-a, all controlled substance prescriptions. Spanning Schedule II, III, and IV. Must be issued electronically. This is a critical distinction from most states, which only require EPCS for Schedule II substances.
Here is how NH EPCS applies to common depression medications:
In practice, most depression medications are non-scheduled and EPCS is entirely inapplicable. The key exception is Spravato, which triggers both the NH EPCS requirement and federal REMS restrictions. This is different from states like Hawaii, where RSA 318-B:21-a’s counterpart (HRS § 329-38.5) only covers Schedule II. Meaning Spravato would not trigger EPCS in Hawaii but does in New Hampshire.
OptumRx uses a tiered formulary structure. Your exact cost-sharing depends on your specific UHC plan, but the following reflects typical OptumRx commercial formulary placement for depression medications in 2026:
| Medication | Formulary Tier | Prior Auth? | NH EPCS |
|---|---|---|---|
| Generic SSRIs (fluoxetine, sertraline, escitalopram) | Tier 1. 2 | Generally no | N/A (non-scheduled) |
| Generic SNRIs (venlafaxine, duloxetine) | Tier 1. 2 | Generally no | N/A (non-scheduled) |
| Bupropion (generic) | Tier 1. 2 | Generally no | N/A (non-scheduled) |
| Mirtazapine (generic) | Tier 1. 2 | Generally no | N/A (non-scheduled) |
| Brand SSRIs/SNRIs (Lexapro, Effexor XR brand) | Tier 3. 4 | Often; step therapy required | N/A (non-scheduled) |
| Trintellix (vortioxetine) | Tier 3. 4 | PA likely; step therapy | N/A (non-scheduled) |
| Auvelity (bupropion/dextromethorphan) | Tier 3. 4 | PA likely; step therapy | N/A (non-scheduled) |
| Spravato (esketamine nasal spray) | Specialty tier | PA required; REMS applies | Required (Schedule III. RSA 318-B:21-a) |
Coverage varies by plan. Always verify your specific benefits through your UHC member portal, the OptumRx app, or by calling the member services number on your insurance card.
UHC and OptumRx apply prior authorization (PA) requirements to certain higher-cost depression medications. Understanding how PA works can help you avoid delays in starting treatment.
UHC plans using OptumRx commonly require “step therapy” for brand-name antidepressants. Meaning you may need to try and document a trial of a generic equivalent before the plan will cover the brand-name version. Your provider can request a step therapy exception if there is a clinical reason to start with the brand-name medication.
If your PA request or claim is denied, you have the right to appeal. UHC’s standard appeal process includes:
Beyond medication, depression treatment typically involves therapy, and UHC plans in New Hampshire are required to cover behavioral health services on parity with medical benefits under RSA 417-E:1.
Use the UHC online provider directory at myuhc.com or the Health4Me app to find in-network therapists and psychiatrists in New Hampshire. Telehealth greatly expands access. Many Klarity Health providers serving New Hampshire patients are able to see patients via video visits, removing geographic barriers for those in rural or northern NH communities.
Telehealth coverage for depression treatment has expanded significantly under UHC plans. For New Hampshire residents, telehealth may be particularly valuable given the state’s rural geography and provider shortage in northern and western counties.
UHC commercial plans in New Hampshire generally cover:
Under NH state law and federal telehealth parity requirements, UHC may not charge higher copays for telehealth mental health visits than for equivalent in-person visits.
Klarity Health connects patients with licensed psychiatric providers who can evaluate and treat depression online. Including prescribing antidepressants when clinically appropriate. With a network of 2,000+ licensed providers, Klarity offers same-week appointments in most states, including New Hampshire.
Here’s how the coverage process typically works:
Check If Your UHC Plan May Cover Depression Treatment →
New Hampshire’s mental health parity law, RSA 417-E:1 et seq., requires insurers to cover mental health and substance use disorder services on equal terms with medical and surgical benefits. Key protections include:
If you believe UHC is applying more restrictive criteria to your depression treatment than to comparable medical conditions, contact the NH Insurance Department at 1-800-852-3416 to file a parity complaint.
Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation. It is categorized as a Schedule III controlled substance and is administered only in certified healthcare settings under a REMS program.
In New Hampshire, because RSA 318-B:21-a covers all controlled substances Schedule II through IV, Spravato prescriptions require electronic prescribing. This is handled by the certified healthcare facility administering the treatment. Patients do not need to take any additional steps.
Under OptumRx, Spravato coverage typically requires:
If you believe Spravato may be appropriate for your situation, discuss it with your psychiatrist, who can initiate the PA process with OptumRx.
Not all depression-related treatments may be covered under your UHC plan. Coverage exclusions to be aware of include:
Most UHC plans cover generic antidepressants at Tier 1. 2 through OptumRx with low or no cost-sharing. Brand-name medications typically require prior authorization and may require step therapy. Coverage details depend on your specific plan and formulary year.
It depends on your plan type. PPO plans generally do not require a referral for specialist visits, including psychiatry. HMO plans may require a referral from your primary care provider. Check your plan documents or call the member number on your card.
Yes. New Hampshire RSA 417-E:1 requires mental health parity. UHC may not apply more restrictive coverage rules to depression treatment than to comparable physical conditions. Federal MHPAEA applies to employer self-funded plans.
Spravato is typically covered under specialty benefit with prior authorization for qualifying patients with treatment-resistant depression. Because it is a Schedule III controlled substance, it also requires electronic prescribing under NH RSA 318-B:21-a. Though this is managed by the certified healthcare facility. Contact OptumRx at 1-800-788-4863 or your UHC member services for plan-specific details.
Most UHC commercial plans cover telehealth psychiatric visits, including medication management for depression. Video and phone visits with in-network providers are typically reimbursed at the same rate as in-person visits under NH telehealth parity requirements.
You have the right to appeal. Start with a Level 1 internal appeal within 180 days of denial. If denied again, request external review through the NH Insurance Department (1-800-852-3416). Your prescribing provider can also submit a medical necessity letter or step therapy exception to support your appeal.
Disclaimer: This article is for informational purposes only and does not constitute insurance, legal, or medical advice. Coverage details vary by specific plan, employer, and formulary year. Always verify your benefits directly with UnitedHealthcare before beginning treatment. Klarity Health is not affiliated with UnitedHealthcare or OptumRx.
Find the right provider for your needs — select your state to find expert care near you.